Results 151 to 160 of about 1,005 (173)

The Italian multicenter cohort of the Post Authorization Safety Study on pitolisant (PASS-pitolisant) in narcolepsy: response to treatment

Sleep Medicine, 2022
M. Figorilli, C. Mutti, V. Brunetti, P. Proserpio, C. Liguori, I. Lecomte, N. Blanchard, T. Sacco, P. Giuseppe   +8 more
openaire   +1 more source

Pitolisant

Reactions Weekly, 2015
openaire   +1 more source

Effects of pitolisant on nighttime sleep

Sleep Medicine, 2019
A. Triller, H. Hidalgo, U. Kallweit
openaire   +1 more source

Pitolisant for the treatment of narcolepsy with or without cataplexy.

Medizinische Monatsschrift fur Pharmazeuten, 2018
Since March 2016, a new treatment option for adult patients with narcolepsy – with or without cataplexy – has been granted marketing authorization in Europe. Pitolisant (Wakix®) is an inverse agonst at the histamine-3 (H3) receptor. In clinical studies, tests for measurement of wakefulness and attention, pitolisant showed significantly better results ...
openaire   +1 more source

Pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: A meta-analysis from randomized controlled trials

Pharmacological Research, 2021
Jiahe Wang, Heng Gao
exaly  

Pitolisant for Treating Narcolepsy Comorbid With Schizophrenia

Journal of Clinical Psychopharmacology, 2020
Clément Dondé, Mircea Polosan, Rita Guzun   +2 more
openaire   +1 more source

Post authorization safety study on pitolisant (PASS-pitolisant) in narcolepsy: Response to treatment from the Italian multicenter cohort

Journal of the Neurological Sciences, 2021
Michela Figorilli, Carlotta Mutti, Valerio Brunetti, Paola Proserpio, Claudio Liguori, Isabelle Lecomte, Nora Blanchard, Tommaso Sacco, Giuseppe Plazzi   +8 more
openaire   +1 more source

<p>Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility</p>

Nature and Science of Sleep, 2020
Jay T Guevarra, Robert Hiensch, Andrew W Varga   +2 more
exaly  

Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: Dose-dependent effects in the human photosensitivity model

Epilepsy and Behavior, 2013
Dorothee Kasteleijn-Nolst Trenité, Pierre Genton, Edouard Hirsch   +2 more
exaly  

Methylphenidate/pitolisant/venlafaxine interaction

Reactions Weekly, 2020
openaire   +1 more source